Trial Details
RECRUITINGBasic Information
| Clinical ID | c1110 |
|---|---|
| Identifier | NCT05442567 |
| Trial Title | A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Vedolizumab IV|OTHER: No Intervention |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-05-16 |
|---|---|
| Primary Completion Date | 2031-08-15 |
| Completion Date | 2031-08-15 |